Depending on the cellular context, SETDB1 can act either as a proto-oncogene, by silencing tumor suppressor genes such as APOE, p53 and HoxA, or as a tumor suppressor through the downregulation of the oncogene ANXA2 [18]. Here, ANXA2 is linked to neoplasm.